CSIMarket
 
Strata Skin Sciences Inc   (NASDAQ: SSKN)
Other Ticker:  
 
 
Price: $3.0800 $0.05 1.650%
Day's High: $3.09 Week Perf: 3.04 %
Day's Low: $ 3.02 30 Day Perf: -4.94 %
Volume (M): 2 52 Wk High: $ 6.90
Volume (M$): $ 6 52 Wk Avg: $3.96
Open: $3.02 52 Wk Low: $2.51



 Market Capitalization (Millions $) 11
 Shares Outstanding (Millions) 4
 Employees 96
 Revenues (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 4

Strata Skin Sciences Inc
Strata Skin Sciences Inc is a medical technology company primarily focused on the dermatology market. The company develops, manufactures, and markets innovative devices for treating various skin conditions and diseases. Their flagship product is the XTRAC laser system, which is used to treat psoriasis, vitiligo, and other skin disorders.

The XTRAC laser system uses a targeted phototherapy technology that delivers concentrated ultraviolet light to affected areas of the skin, providing a safe and effective treatment option. The company also provides training, support, and service to healthcare professionals who use their devices.

In addition to the XTRAC laser system, Strata Skin Sciences Inc offers other dermatological devices, such as the Nordlys device for vascular and pigmented lesions, and the STRATAPEN microneedling device for skin rejuvenation and scar treatment.

The company has a global presence and serves customers in over 70 countries. They are committed to continuous innovation and investing in research and development to expand their product portfolio and improve patient outcomes.


   Company Address: 5 Walnut Grove Drive Horsham 19044 PA
   Company Phone Number: 619-3200   Stock Exchange / Ticker: NASDAQ SSKN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        1.2% 
BSX        1.63% 
CNMD        0.58% 
IART        0.58% 
MDT   -1.74%    
OSUR   -0.75%    
• View Complete Report
   



Product Service News

STRATA Skin Sciences Achieves Legal Victory Amidst Market Challenges

Published Mon, Nov 11 2024 1:15 PM UTC

In a notable development that may signal a turning tide for STRATA Skin Sciences, Inc. (NASDAQ: SSKN), the medical technology firm has recently secured a favorable ruling from the United States District Court for the Eastern District of Pennsylvania. This court order comes as a positive advance in the company?s ongoing complaint against a trio of defendants: LaserOptek Ameri...

Stocks on the Move

Strata Skin Sciences? Stock Stumble A Promising Therapy Clouded by Financial Concerns, refusal null

Published Tue, Aug 6 2024 9:11 PM UTC

Behind the Decline: Why Strata Skin Sciences Inc Shares Are Lagging the MarketIn recent days, the shares of Strata Skin Sciences Inc (NASDAQ: SSKN) have found themselves on a downward trajectory, trailing the performance of the broader market despite noteworthy advancements in its technology and promising developments in acne treatment. This paradox raises questions about t...

Management Announcement

Faith in Future Prospects: STRATA Skin Sciences Raises $2.1 Million in Direct Offering with Insider and Shareholder Participation Amidst Challenging Financial Climate

Published Tue, Jul 23 2024 12:01 PM UTC


: July 23, 2024
Horsham, PA - STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leading medical technology company specializing in innovative dermatologic treatments, has recently completed a registered direct offering to raise $2.1 million. The offering, priced at-the-market under Nasdaq rules, saw the issuance and sale of 665,136 shares of common stock at an average pu...

Product Service News

STRATA Skin Sciences Gains Japanese Approval for Cutting-Edge XTRAC Momentum 1.0 Dermatologic Device

Published Mon, Jul 22 2024 12:01 PM UTC

STRATA Skin Sciences Announces Regulatory Approval of XTRAC Momentum 1.0 Device in JapanHORSHAM, Penn., July 22, 2024 STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leader in medical technology focused on the development, commercialization, and marketing of innovative dermatologic treatments, has announced the official approval of its XTRAC Momentum 1.0 device by Japan s Mi...

Clinical Study

TheraClearX Acne Therapy System A Safe and Effective Treatment Modality for Mild to Moderate Acne

Published Wed, Jul 17 2024 12:01 PM UTC

Acne is one of the most common skin conditions affecting millions of individuals worldwide. It not only leads to physical symptoms like redness, inflammation, and scarring but also impacts psychological well-being, self-esteem, and quality of life. As a result, finding effective acne treatment options is crucial. This article examines the groundbreaking study published in th...







Strata Skin Sciences Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com